Viewing StudyNCT00003875

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00003875
Status: COMPLETED
Last Update Posted: 2017-06-05
First Post: 1999-11-01
Brief Title: Busulfan and Etoposide Followed by Peripheral Blood Stem Cell Transplant and Low-Dose Aldesleukin in Treating Patients With Acute Myeloid Leukemia
Sponsor: Fred Hutchinson Cancer Center
Organization: Fred Hutchinson Cancer Center
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Recurrent Childhood Acute Myeloid Leukemia
Adult Acute Myeloid Leukemia in Remission
Adult Acute Myeloid Leukemia With 11q23 MLL Abnormalities
Adult Acute Myeloid Leukemia With Del5q
Adult Acute Myeloid Leukemia With t1517q22q12
Adult Acute Myeloid Leukemia With t1616p13q22
Childhood Acute Myeloid Leukemia in Remission
Recurrent Adult Acute Myeloid Leukemia
Keywords: